SCHEMBL29628495

SCHEMBL29628495

FC(F)(F)Oc1ccnc(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 1/20 0.43
TSPO P30536 1/20 0.43
GRM5 P41594 1/20 0.43
KCNH2 Q12809 1/20 0.43
TMEM97 Q5BJF2 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
GPR35 Q9HC97 1/20 0.43
GPR3 P46089 1/20 0.40
RECQL P46063 1/20 0.38
LOX P28300 1/20 0.38
LOXL3 P58215 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.38
SMARCA2 P51531 1/20 0.37
SMARCA4 P51532 1/20 0.37
MPI P34949 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
GMNN O75496 1/20 0.37
USP2 O75604 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2303394 1.00 ADRB3 (0.43) ADRB3TSPOGRM5KCNH2TMEM97
SCHEMBL23111687 0.88 RAF1 (0.47) ADRB3TSPOGRM5KCNH2TMEM97
SCHEMBL30816945 0.88 RAF1 (0.47) ADRB3TSPOGRM5KCNH2TMEM97
SCHEMBL27314356 0.82 GRM5 (0.37) ADRB3TSPOGRM5KCNH2TMEM97
SCHEMBL2301174 0.82 RECQL (0.39) ADRB3TSPOGRM5KCNH2TMEM97
SCHEMBL15057624 0.81 DYRK1A (0.48) GRM5KCNH2MPISCN9ADYRK1A
SCHEMBL1229896 0.80 SCN5A (0.49) ADRB3TSPOGRM5KCNH2TMEM97
SCHEMBL27314314 0.78 GRM5 (0.37) ADRB3TSPOGRM5KCNH2TMEM97
SCHEMBL30864848 0.78 GRM5 (0.37) ADRB3TSPOGRM5KCNH2TMEM97
SCHEMBL27160490 0.78 KCNN3 (0.47) RECQLLOXLOXL3LOXL2KCNN3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4687883-A2 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE Caraway Therapeutics, Inc. (US) 2026-02-11 EP disclosed
CN-119585250-A KIT inhibitors 蓝图药品公司 2025-03-07 CN disclosed
WO-2024211249-A2 MODULATORS OF TRPML, THEIR COMPOSITIONS AND METHODS OF USE CARAWAY THERAPEUTICS, INC. (US) 2024-10-10 WO disclosed
CN-117425656-A Purine derivatives as anticancer agents 探戈医药股份有限公司 2024-01-19 CN disclosed
EP-3997096-A1 NEW HETEROCYCLIC COMPOUNDS F. Hoffmann-La Roche AG (CH) 2022-05-18 EP disclosed